To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

January 3, 2017

Study Completion Date

January 3, 2017

Conditions
Beta-Thalassemia
Interventions
OTHER

Quality of Life (QOL) questionnaires

Monitoring of FACT-AN, SF-36V2, TransQol, and NTD PRO assessments,

OTHER

Healthcare Resource Utilization

Monitoring and reviewing HealthCare Resource Utilization information.

Trial Locations (5)

1330

Cukurova University Medical Faculty Balcali Hospital, Çukurova

10700

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

11527

Aghia Sofia Children's Hosptial, Athens

20122

Fondazione IRCCS Ca Granda Ospedale Maggiore, Milan

4407 2020

American University of Beirut Medical Center, Beirut

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY